Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8921 - 8928 of 12107 results
Limiting Securities Litigation Risks in EB-5 Offerings: What Regional Centers and Issuers Need to Know
November 29, 2015| Advisory| Viewpoint
FDA Finalizes Genetically Engineered Food Labeling Guidance & Approves “AquAdvantage Salmon”
November 25, 2015| Blog| Viewpoint
Federal Court Requires “Meeting of the Minds” To Enforce Arbitration Agreement Included in Employment Application
November 24, 2015| Blog| Viewpoint
Webinar Postponed - Post-Safe Harbor Update for Life Sciences Companies
November 24, 2015| Blog| Viewpoint
FDA Commits to Moving Forward with LDT Regulation
November 24, 2015| Blog| Viewpoint
HHS Drug Pricing Forum Highlighted in ML Strategies' Health Care Update
November 24, 2015| Blog| Viewpoint
Truthful Terminations May Lead to Better Consequences
November 23, 2015| Blog| Viewpoint
Offering Pre-Tax Transit Benefits is no Longer Optional for New York City Employers
November 23, 2015| Blog| Viewpoint
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|